4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-090469
Chief Business Officer sold 200,000 shares at $8.74 ($1,748,180)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 2020-08-03 | Sale | −200,000 | $8.74 | $1,748,180 | 0 | D: show line 1 in the form |
| Open-market sales · 200,000 sh · avg $8.74 · $1,748,180 | |||||||
Loading xslF345X03/a4.xml…